• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏影像报告和数据系统 CT 和钆塞酸增强 MRI 与弥散加权成像。

Liver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imaging.

机构信息

Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro Gangnam-gu, Seoul, 06351, Republic of Korea.

出版信息

Eur Radiol. 2017 Oct;27(10):4394-4405. doi: 10.1007/s00330-017-4804-1. Epub 2017 Apr 3.

DOI:10.1007/s00330-017-4804-1
PMID:28374073
Abstract

OBJECTIVES

To assess major imaging features of Liver Imaging Reporting and Data System (LI-RADS) on contrast-enhanced CT and gadoxetic acid-enhanced MRI and to estimate whether the combination of signal intensity favouring HCC on hepatobiliary phase (HBP) and diffusion-weighted images (DWI) can act as a major feature in LI-RADS.

METHODS

Four hundred twenty one patients with 445 observations were included. Major features of LI-RADS on CT and MRI as well as HBP and DWI features were assessed. Diagnostic performances of LR-5 according to LI-RADS v2014 and modified LI-RADS which incorporate combination of HBP and DWI were assessed. Pairwise comparisons of the receiver operating characteristic (ROC) curves were performed.

RESULTS

For HCCs, capsule appearance had the highest rate of discordance between CT and MRI (32.7%), followed by washout appearance (22.2%). Specificity (75%) of LR-5 of LI-RADS v2014 was lower than that (77.1-79.2%) of modified LI-RADS. Area under the ROC curve of modified LI-RADS (0.755-0.775) was not significantly different from that of LI-RADS v 2014 (0.709) (p > 0.05).

CONCLUSIONS

There were substantial discordances between CT and MRI for capsule and washout appearances in hepatic observations, and combination of gadoxetic acid-enhanced MRI and DWI might be able to be incorporated as a major feature of LI-RADS.

KEY POINTS

• Major imaging features of LI-RADS showed substantial discordances on CT and MRI. • An observation may be categorized differently depending on used imaging exam. • CT and MRI should both be performed for LR-3 and LR-4 observations. • Combination of gadoxetic acid-enhanced MRI and DWI may be a major feature.

摘要

目的

评估对比增强 CT 和钆塞酸增强 MRI 的肝脏影像报告和数据系统(LI-RADS)的主要影像学特征,并评估肝胆期(HBP)和弥散加权成像(DWI)上的信号强度是否有利于肝癌的表现是否可以作为 LI-RADS 的主要特征。

方法

共纳入 421 例 445 个病灶患者。评估 CT 和 MRI 上的 LI-RADS 主要特征以及 HBP 和 DWI 特征。根据 LI-RADS v2014 和纳入 HBP 和 DWI 组合的改良 LI-RADS 评估 LR-5 的诊断性能。进行了 ROC 曲线的两两比较。

结果

对于 HCC,包膜外观在 CT 和 MRI 之间的不符率最高(32.7%),其次是洗脱外观(22.2%)。LI-RADS v2014 的 LR-5 的特异性(75%)低于改良 LI-RADS(77.1%-79.2%)。改良 LI-RADS 的 ROC 曲线下面积(0.755-0.775)与 LI-RADS v2014(0.709)无显著差异(p>0.05)。

结论

肝脏观察中 CT 和 MRI 在包膜和洗脱外观方面存在很大差异,并且钆塞酸增强 MRI 和 DWI 的组合可能能够被纳入 LI-RADS 的主要特征。

关键点

  1. LI-RADS 的主要影像学特征在 CT 和 MRI 上存在很大差异。

  2. 取决于所使用的成像检查,观察结果可能会分类不同。

  3. 对于 LR-3 和 LR-4 观察,应同时进行 CT 和 MRI。

  4. 钆塞酸增强 MRI 和 DWI 的组合可能是一个主要特征。

相似文献

1
Liver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imaging.肝脏影像报告和数据系统 CT 和钆塞酸增强 MRI 与弥散加权成像。
Eur Radiol. 2017 Oct;27(10):4394-4405. doi: 10.1007/s00330-017-4804-1. Epub 2017 Apr 3.
2
Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS.采用扩散加权成像的细胞外对比增强 MRI 对 HCC 诊断的前瞻性比较:与使用 LI-RADS 的钆塞酸对比剂的比较。
Eur Radiol. 2020 Jul;30(7):3723-3734. doi: 10.1007/s00330-020-06753-5. Epub 2020 Mar 3.
3
Liver imaging reporting and data system (LI-RADS) v2018: comparison between computed tomography and gadoxetic acid-enhanced magnetic resonance imaging.肝脏影像报告和数据系统(LI-RADS)v2018:计算机断层扫描与钆塞酸增强磁共振成像的比较。
Jpn J Radiol. 2019 Sep;37(9):651-659. doi: 10.1007/s11604-019-00855-x. Epub 2019 Jul 18.
4
Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?肝细胞癌:钆塞酸增强磁共振和弥散加权成像的 LI-RADS v2017 能否提高诊断准确性?
World J Gastroenterol. 2019 Feb 7;25(5):622-631. doi: 10.3748/wjg.v25.i5.622.
5
LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI.LI-RADS v2014 肝细胞癌分类:钆喷酸葡胺增强 MRI 与钆塞酸二钠增强 MRI 的个体内比较。
Eur Radiol. 2019 Jan;29(1):401-410. doi: 10.1007/s00330-018-5559-z. Epub 2018 Jun 19.
6
Added Value of sequentially performed gadoxetic acid-enhanced liver MRI for the diagnosis of small (10-19 mm) or atypical hepatic observations at contrast-enhanced CT: A prospective comparison.序贯式钆塞酸增强肝脏 MRI 对 CT 增强扫描中发现的小(10-19mm)或不典型肝脏病灶的诊断价值:一项前瞻性比较。
J Magn Reson Imaging. 2019 Feb;49(2):574-587. doi: 10.1002/jmri.26199. Epub 2018 Aug 13.
7
Diagnostic accuracy of liver imaging reporting and data system (LI-RADS) v2014 for intrahepatic mass-forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid-enhanced MRI.肝脏影像报告和数据系统(LI-RADS)v2014对慢性肝病患者钆塞酸二钠增强MRI检查中肝内肿块型胆管癌的诊断准确性
J Magn Reson Imaging. 2016 Nov;44(5):1330-1338. doi: 10.1002/jmri.25287. Epub 2016 Apr 18.
8
Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017).在 1.5T 场强下使用肝脏影像报告和数据系统(LI-RADS v.2017)评估钆塞酸二钠与钆喷替酸葡甲胺对比用于肝细胞癌检测的效能。
Cancer Imaging. 2018 Dec 7;18(1):48. doi: 10.1186/s40644-018-0183-3.
9
Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI.前瞻性应用肝脏成像报告和数据系统(LI-RADS)在钆塞酸增强 MRI 中的诊断准确性。
Eur Radiol. 2018 May;28(5):2038-2046. doi: 10.1007/s00330-017-5188-y. Epub 2017 Dec 11.
10
Added value of enhanced CT on LR-3 and LR-4 observation of Gd-EOB-DTPA MRI for the diagnosis of HCC: are CT and MR washout features interchangeable?钆塞酸二钠增强 MRI 中 LR-3、LR-4 观察对 HCC 诊断的 CT 增强的附加价值:CT 和 MR 洗脱特征是否可互换?
Br J Radiol. 2022 Apr 1;95(1132):20210738. doi: 10.1259/bjr.20210738. Epub 2022 Jan 5.

引用本文的文献

1
Current State of Evidence for Use of MRI in LI-RADS.肝脏影像报告和数据系统(LI-RADS)中使用MRI的证据现状
J Magn Reson Imaging. 2025 Sep;62(3):640-653. doi: 10.1002/jmri.29748. Epub 2025 Feb 21.
2
Common pitfalls and diagnostic challenges in the application of LI-RADS CT/MRI algorithms: a comprehensive review.LI-RADS CT/MRI算法应用中的常见陷阱与诊断挑战:全面综述
Abdom Radiol (NY). 2024 Dec 24. doi: 10.1007/s00261-024-04778-8.
3
Value of magnetic resonance imaging for diagnosis of LR‑3 and LR-4 lesions coexisting with hepatocellular carcinoma.

本文引用的文献

1
Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging.肝硬化小型肝内胆管细胞癌和肝细胞癌在多期动态磁共振成像上可能具有相似的强化模式。
Radiology. 2016 Oct;281(1):150-7. doi: 10.1148/radiol.2016151205. Epub 2016 Apr 14.
2
Current update on combined hepatocellular-cholangiocarcinoma.肝细胞胆管癌联合诊疗的最新进展
Eur J Radiol Open. 2014 Sep 6;1:40-8. doi: 10.1016/j.ejro.2014.07.001. eCollection 2014.
3
Diagnostic criteria for hepatocellular carcinoma ⩽3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging.
磁共振成像对合并肝细胞癌的 LR-3 和 LR-4 病变的诊断价值。
Abdom Radiol (NY). 2024 Aug;49(8):2629-2638. doi: 10.1007/s00261-024-04338-0. Epub 2024 Jun 5.
4
Performance of LI-RADS category 5 vs combined categories 4 and 5: a systemic review and meta-analysis.LI-RADS 类别 5 与类别 4 和 5 联合的表现:系统评价和荟萃分析。
Eur Radiol. 2024 Nov;34(11):7025-7040. doi: 10.1007/s00330-024-10813-5. Epub 2024 May 29.
5
Differences between CEUS LI-RADS and CECT LI-RADS in the diagnosis of focal liver lesions in patients at risk for HCC.CEUS LI-RADS 与 CECT LI-RADS 在 HCC 高危患者局灶性肝脏病变诊断中的差异。
BMC Med Imaging. 2023 Sep 11;23(1):122. doi: 10.1186/s12880-023-01088-1.
6
A Multicenter Assessment of Interreader Reliability of LI-RADS Version 2018 for MRI and CT.LI-RADS 版本 2018 用于 MRI 和 CT 的多中心读者间可靠性评估
Radiology. 2023 Jun;307(5):e222855. doi: 10.1148/radiol.222855.
7
Diagnostic Values of the Liver Imaging Reporting and Data System in the Detection and Characterization of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.肝脏影像报告和数据系统在肝细胞癌检测与特征描述中的诊断价值:一项系统评价和Meta分析
Cureus. 2023 Mar 13;15(3):e36082. doi: 10.7759/cureus.36082. eCollection 2023 Mar.
8
Utilization of a Machine Learning Algorithm for the Application of Ancillary Features to LI-RADS Categories LR3 and LR4 on Gadoxetate Disodium-Enhanced MRI.利用机器学习算法将辅助特征应用于钆塞酸二钠增强MRI上的LI-RADS分类LR3和LR4
Cancers (Basel). 2023 Feb 21;15(5):1361. doi: 10.3390/cancers15051361.
9
Gadoxetic acid-enhanced MRI with a focus on LI-RADS v2018 imaging features predicts the prognosis after radiofrequency ablation in small hepatocellular carcinoma.钆塞酸增强磁共振成像聚焦于LI-RADS v2018成像特征可预测小肝细胞癌射频消融术后的预后。
Front Oncol. 2023 Feb 2;13:975216. doi: 10.3389/fonc.2023.975216. eCollection 2023.
10
HCC or Something Else? Frequency of Various Benign and Malignant Etiologies in Cirrhotic Patients with Newly Detected Focal Liver Lesions in Relation to Different Clinical and Sonographic Parameters.肝细胞癌还是其他病症?肝硬化患者新发现局灶性肝病变的各种良性和恶性病因的发生率与不同临床及超声参数的关系
Diagnostics (Basel). 2022 Aug 28;12(9):2079. doi: 10.3390/diagnostics12092079.
肝细胞癌 ⩽3 cm 的肝细胞特异性对比增强磁共振成像的诊断标准。
J Hepatol. 2016 May;64(5):1099-1107. doi: 10.1016/j.jhep.2016.01.018. Epub 2016 Jan 25.
4
Differences in Liver Imaging and Reporting Data System Categorization Between MRI and CT.MRI 与 CT 检查在肝脏影像报告和数据系统分类中的差异。
AJR Am J Roentgenol. 2016 Feb;206(2):307-12. doi: 10.2214/AJR.15.14788.
5
Liver Imaging Reporting and Data System:: Substantial Discordance Between CT and MR for Imaging Classification of Hepatic Nodules.肝脏影像报告和数据系统:CT与MR在肝结节影像分类上存在显著差异。
Acad Radiol. 2016 Mar;23(3):344-52. doi: 10.1016/j.acra.2015.11.002. Epub 2016 Jan 7.
6
Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.钆塞酸二钠增强磁共振成像(MRI)与扩散加权成像(DWI)联合应用于慢性肝病所致肝细胞癌诊断的Meta分析
PLoS One. 2015 Dec 2;10(12):e0144247. doi: 10.1371/journal.pone.0144247. eCollection 2015.
7
Hepatocellular carcinoma: A comprehensive review.肝细胞癌:全面综述。
World J Hepatol. 2015 Nov 18;7(26):2648-63. doi: 10.4254/wjh.v7.i26.2648.
8
Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.钆塞酸二钠增强肝脏磁共振成像上肝内肿块型胆管癌与肝细胞癌的鉴别诊断
Eur Radiol. 2016 Jun;26(6):1808-17. doi: 10.1007/s00330-015-4005-8. Epub 2015 Sep 15.
9
ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents.欧洲胃肠道和腹部放射学会关于肝脏磁共振成像及肝脏特异性对比剂临床应用的共识声明。
Eur Radiol. 2016 Apr;26(4):921-31. doi: 10.1007/s00330-015-3900-3. Epub 2015 Jul 21.
10
Classifying CT/MR findings in patients with suspicion of hepatocellular carcinoma: Comparison of liver imaging reporting and data system and criteria-free Likert scale reporting models.对疑似肝细胞癌患者的CT/MR检查结果进行分类:肝脏影像报告和数据系统与无标准李克特量表报告模型的比较
J Magn Reson Imaging. 2016 Feb;43(2):373-83. doi: 10.1002/jmri.24987. Epub 2015 Jun 26.